These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21926921)

  • 1. Delivery of therapeutic agents to the target tissue.
    Archer DF
    Menopause; 2011 Oct; 18(10):1040-1. PubMed ID: 21926921
    [No Abstract]   [Full Text] [Related]  

  • 2. Endometrial safety: a key hurdle for selective estrogen receptor modulators in development.
    Pinkerton JV; Goldstein SR
    Menopause; 2010; 17(3):642-53. PubMed ID: 20107426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women: systematic review and meta-analysis.
    Somboonporn W; Panna S; Temtanakitpaisan T; Kaewrudee S; Soontrapa S
    Menopause; 2011 Oct; 18(10):1060-6. PubMed ID: 21720280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer and contraception. Release date May 2012. SFP Guideline #20121.
    Patel A; Schwarz EB;
    Contraception; 2012 Sep; 86(3):191-8. PubMed ID: 22682881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic Therapies in Women's Health: Contraception and Menopause Treatment.
    Allen C; Evans G; Sutton EL
    Med Clin North Am; 2016 Jul; 100(4):763-89. PubMed ID: 27235614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary heart disease in women.
    Anderson PW; Moscarelli E
    N Engl J Med; 2000 Dec; 343(25):1892; author reply 1892-4. PubMed ID: 11117987
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.
    Riggs BL; Hartmann LC
    N Engl J Med; 2003 Feb; 348(7):618-29. PubMed ID: 12584371
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hormonal treatments for hemorrhaging secondary to fibroids. An alternative or complement to surgery?].
    Cancelo Hidalgo MJ
    Med Clin (Barc); 2013 Jul; 141 Suppl 1():30-4. PubMed ID: 24314565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [SERMs: mechanisms of action and therapeutic indications].
    Malville E
    Ann Endocrinol (Paris); 2003 Dec; 64(6):481-2. PubMed ID: 15080159
    [No Abstract]   [Full Text] [Related]  

  • 11. Endocrine resistance in breast cancer.
    Zheng LH; Zhao YH; Feng HL; Liu YJ
    Climacteric; 2014 Oct; 17(5):522-8. PubMed ID: 24245601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the endometrial histologic effects of progestins and progesterone receptor modulators in reproductive age women.
    Dinh A; Sriprasert I; Williams AR; Archer DF
    Contraception; 2015 May; 91(5):360-7. PubMed ID: 25596512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].
    Kozakiewicz K; Wycisk A
    Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal therapy for endometriosis: from molecular research to bedside.
    Tosti C; Biscione A; Morgante G; Bifulco G; Luisi S; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():61-66. PubMed ID: 27503693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-estrogens, selective estrogen receptor modulators (SERM), tibolone: modes of action].
    Maudelonde T; Brouillet JP; Pujol P
    Contracept Fertil Sex; 1999 Sep; 27(9):620-4. PubMed ID: 10540506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment guideline for breast cancer and SERM-treatment].
    Iwase H; Yamamoto Y; Kawasoe T
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():636-40. PubMed ID: 18159717
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormal uterine bleeding: Taking the stress out of controlling the flow.
    Farrukh JB; Towriss K; McKee N
    Can Fam Physician; 2015 Aug; 61(8):693-7. PubMed ID: 26273083
    [No Abstract]   [Full Text] [Related]  

  • 18. Current and evolving approaches to individualizing estrogen receptor-based therapy for menopausal women.
    Santen RJ; Kagan R; Altomare CJ; Komm B; Mirkin S; Taylor HS
    J Clin Endocrinol Metab; 2014 Mar; 99(3):733-47. PubMed ID: 24423357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal management of abnormal uterine bleeding.
    Singh RH; Blumenthal P
    Clin Obstet Gynecol; 2005 Jun; 48(2):337-52. PubMed ID: 15805791
    [No Abstract]   [Full Text] [Related]  

  • 20. [Breast cancer].
    Iwase H
    Nihon Rinsho; 2006 Sep; Suppl 3():379-83. PubMed ID: 17022569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.